Conditions: Chronic Kidney Disease Secondary Hyperparathyroidism
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 313
Healthy volunteers: no

Brief summary:
Randomized Trial to Evaluate the Efficacy and Safety of Cinacalcet Treatment in Combination with Low Dose Vitamin D for the Treatment of Subjects with Secondary Hyperparathyroidism (SHPT) Recently Initiating Hemodialysis

Detailed description:

Arms:
arm 1: Cinacalcet plus low dose active Vitamin D (if prescribed) arm 2: Flexible active vitamin D dosing

Interventions: intervention 1: Cinacalcet intervention 2: Vitamin D
Intervention descriptions: intervention 1: Cinacalcet is a calcimimetic agent, which is synthesized as a hydrochloride salt. intervention 2: Titration of active Vitamin D in accordance with treatment practice guidelines in order to treat Secondary Hyperparathyroidism.

Protocol document: